Refractory Diffuse Large B-Cell Lymphoma

Explore clinical trials studying Refractory Diffuse Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

66 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Refractory Diffuse Large B-Cell Lymphoma trial results

Active, Not Recruiting

NCT04572763

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: City of Hope Cancer Center Duarte, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Siteman Cancer Center at Washington University St Louis, Missouri, United States

Active, Not Recruiting

NCT03015896

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Active, Not Recruiting

NCT02992522

Conditions: B-Cell, B-Cell Lymphoma, Unspecified, Burkitt Lymphoma, +30 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Active, Not Recruiting

NCT04007029

Conditions: CD19 Positive, CD20 Positive, Chronic Disease, +33 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Active, Not Recruiting

NCT03150329

Conditions: Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +25 more
Locations: City of Hope Medical Center Duarte, California, United States

Active, Not Recruiting

NCT04665765

Conditions: Diffuse Large B-Cell Lymphoma Unclassifiable, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

Emory University Atlanta, Georgia, United States